Kisqali 600 MG daily dose UU 63S
Ended Awarded Last action
- Contract number
- SPE2DR26FT5UB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $85,960
Award facts
- Contract value 100% obligated
- $85,960.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $85,960 to AmerisourceBergen Drug Corp for the supply of Kisqali 600 mg daily dose tablets (63-count units) on January 28, 2026, with completion expected by February 19, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor to federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999 and extending through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide. The contract demonstrates AmerisourceBergen's established capability to compete successfully in open competition and efficiently fulfill essential pharmaceutical needs for military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FT5UB?
SPE2DR26FT5UB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FT5UB worth?
The government has obligated $85,960 on SPE2DR26FT5UB.
Is contract SPE2DR26FT5UB an order under another contract?
Yes. SPE2DR26FT5UB is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5UB competed?
The extent of competition for SPE2DR26FT5UB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award